|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.191 RON | +2.69% |
|
+0.53% | -4.50% |
| 2023 | S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
| 2023 | S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
S.C. Ropharma S.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was RON 501.51 million compared to RON 436.3 million a year ago. Revenue was RON 557.78 million compared to RON 481.19 million a year ago.
Net income was RON 4.47 million compared to RON 3.68 million a year ago. Basic earnings per share from continuing operations was RON 0.009 compared to RON 0.007 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.50% | 21.15M | |
| -15.44% | 3.67B | |
| -5.96% | 3.24B | |
| +19.77% | 2.9B | |
| +7.98% | 2.73B | |
| -9.65% | 1.78B | |
| +12.07% | 1.41B | |
| -19.03% | 982M | |
| -35.34% | 742M | |
| -0.53% | 458M |
S.C. ROPHARMA S.A. 